Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05838456 · ClinicalTrials.gov registry record · NA
Deep Learning Enabled Endovascular Stroke Therapy Screening in Community Hospitals
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 443
- Enrollment target
NCT05838456 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 443 participants.
The verdict
NCT05838456, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 443 participants
- Enrollment target
Study Summary
After onset of Acute Ischemic Stroke (AIS), every minute of delay to treatment reduces the likelihood of a good clinical outcome. A key delay occurs in the time between completion of computed tomography (CT) angiography of the head and neck and interpretation in the setting of AIS care. The purpose of this study is to assess the effect of incorporating Viz.AI software, which via via a machine-learning algorithm performs artificial intelligence-based automated detection of large vessel occlusions (LVO) on CT angiography (CTA) images and alerts the AIS care team (diagnosis and treatment decisions will be based on the clinical evaluation and review of the images by the treating physician, per routine standard of care). The hypothesis is that integration of the software into the AIS care pathway will reduce delays in treatment. A cluster-randomized stepped-wedge trial will be performed across 4 hospitals in the greater Houston area.
Interventions
- DEVICE Viz.AI software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05838456
The ClinicalTrials.gov registry entry for NCT05838456 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 443 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Viz.AI software is the first listed.
NCT05838456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05838456 about?
NCT05838456 is a clinical study titled "Deep Learning Enabled Endovascular Stroke Therapy Screening in Community Hospitals". After onset of Acute Ischemic Stroke (AIS), every minute of delay to treatment reduces the likelihood of a good clinical outcome. A key delay occurs in the time between completion of computed tomography (CT) angiography of the head and neck and interpretation in the setting of AIS care. The purpose...
What is the current status of trial NCT05838456?
This trial is currently completed. It is a NA study. The enrollment target is 443 participants. The study started on 2021-01-01. Estimated completion is 2022-05-27.
What interventions are being tested in trial NCT05838456?
The interventions under investigation include: Viz.AI software (DEVICE).
Who is sponsoring clinical trial NCT05838456?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.